MMP9 and Alzheimer disease: In one study, AD subjects who received resveratrol for 52 weeks had a significant reduction in the expression of cerebrospinal fluid matrix metallopeptidase 9 (MMP-9) and inflammatory markers [457], but in another clinical trial of AD, resveratrol had no beneficial effects [458].